A phase I study of MDM2 antagonist RG7112 in patients (pts) with relapsed/refractory solid tumors.
Razelle Kurzrock
Research Funding - Roche
Jean-Yves Blay
Honoraria - GlaxoSmithKline; Novartis; Pfizer; PharmaMar; Roche
Research Funding - GlaxoSmithKline; Novartis; Pfizer; PharmaMar; Roche
Binh Bui Nguyen
Honoraria - Novartis; PharmaMar
Research Funding - Roche
Andrew J. Wagner
Consultant or Advisory Role - Genentech; Novartis; Pfizer; Sanofi
Research Funding - Genentech; Lilly; Novartis; Pfizer; Roche
Robert G. Maki
Research Funding - Roche
Gary K. Schwartz
Research Funding - Roche
Amita Patnaik
Research Funding - Roche
Lia Gore
Research Funding - Roche
Lin Wu
Employment or Leadership Position - Roche
Stock Ownership - Roche
Lyubomir T Vassilev
Employment or Leadership Position - Roche
Stock Ownership - Roche
Michelle Ding
Employment or Leadership Position - Roche
Stock Ownership - Roche
David Geho
Employment or Leadership Position - Roche
Stock Ownership - Roche
Jianguo Zhi
Employment or Leadership Position - Roche
Stock Ownership - Roche
Steven Middleton
Employment or Leadership Position - Roche
Stock Ownership - Roche
Gwen L. Nichols
Employment or Leadership Position - Roche
Stock Ownership - Roche